Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07152249

Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial

Led by Vanderbilt University Medical Center · Updated on 2026-01-12

19480

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether a new clinical decision support (CDS) tool integrated into the electronic health record can improve the prevention of postoperative nausea and vomiting (PONV) in adults undergoing planned surgery with general anesthesia. The study aims to see if this tool increases the appropriate use of PONV prevention and lowers the rate of PONV compared to standard care. The trial uses a repeated crossover design over 12 months to test the tool's impact on clinical practice and patient outcomes. The intervention involves the AW-D Clinical Decision Support Tool, which delivers automated reminders to anesthesia providers at key times during surgery, such as before surgery starts, after anesthesia induction, and before the patient wakes up. These alerts are personalized based on each patient's risk factors for PONV and serve as reminders rather than mandates. The study alternates between periods when the tool is active and when it is not, including washout and control phases. Participants will be adult patients undergoing general anesthesia with planned surgery. Researchers will monitor how often PONV prevention medications are given appropriately during surgery and track the incidence of PONV within three hours after surgery. They will also measure the length of stay in the post-anesthesia care unit (PACU). The study involves no direct intervention on patients beyond standard care and data collection. The total participation duration varies with each surgical case and immediate postoperative period.

CONDITIONS

Brief Title

Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Planned surgery with general anesthesia using endotracheal intubation or laryngeal mask airway
  • Have zero or more risk factors for postoperative nausea and vomiting, including history of motion sickness or postoperative nausea and vomiting, non-smoking status, female sex, inhalation anesthesia longer than 1 hour, high-risk surgery type (cholecystectomy, laparoscopy, gynecologic), or perioperative opioid use
  • Operating room anesthesia providers caring for eligible patients are included
Not Eligible

You will not qualify if you...

  • ASA status 6 including organ procurement
  • Patients expected to be transferred directly to the intensive care unit while intubated
  • Surgery types excluded: electroconvulsive therapy, intubation-only cases, labor epidurals, transesophageal echocardiography or cardioversion procedures
  • Surgeries lasting less than 30 minutes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - Perioperative period (intraoperative and immediate post-anesthesia)

Participants undergo surgery with general anesthesia and may receive reminders for best practice antiemetic medication administration through the clinical decision support tool during the perioperative period.

1 perioperative period with automated notifications during surgery

Trial Site Locations

Total: 1 location

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37212

Actively Recruiting

Loading map...

Research Team

M

Miklos Kertai, M.D., Ph.D.

G

Gail Mayo

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Similar Trials

Comparison of Remimazolam Alone, Propofol Alone, and Their C...

Postoperative Complications

Actively Recruiting

1 location

Intraoperative Autonomic Blockade to Prevent Early Postopera...

Visceral Pain

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Advancing Strategies to Optimise the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) study: rationale and design for a sequential, repeated crossover trial.

Ellen G Stallings, Jonathan P Wanderer, Mark Balavage...

https://pubmed.ncbi.nlm.nih.gov/41667172